{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T04:37:14Z","timestamp":1727411834059},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.mcna.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:25:27Z","timestamp":1722489927000},"page":"1017-1037","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medical Clinics of North America\u2014Periprocedural Antithrombotics"],"prefix":"10.1016","volume":"108","author":[{"given":"Steven J.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gelovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Von","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Kaatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mcna.2024.04.005_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1213\/ANE.0000000000002183","article-title":"Perioperative Venous Thromboembolism","volume":"125","author":"Gordon","year":"2017","journal-title":"Anesth Analg"},{"issue":"2\u20133","key":"10.1016\/j.mcna.2024.04.005_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.disamonth.2005.02.003","article-title":"Thrombosis Risk Assessment as a Guide to Quality Patient Care","volume":"51","author":"Caprini","year":"2005","journal-title":"Disease-a-Month"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jamcollsurg.2007.02.072","article-title":"Multivariable Predictors of Postoperative Venous Thromboembolic Events after General and Vascular Surgery: Results from the Patient Safety in Surgery Study","volume":"204","author":"Rogers","year":"2007","journal-title":"J\u00a0Am Coll Surg"},{"issue":"03","key":"10.1016\/j.mcna.2024.04.005_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0033-1351130","article-title":"Venous Thromboembolism Prophylaxis","volume":"26","author":"Champagne","year":"2013","journal-title":"Clin Colon Rectal Surg"},{"issue":"2 Suppl","key":"10.1016\/j.mcna.2024.04.005_bib5","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in Nonorthopedic Surgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mcna.2024.04.005_bib6","doi-asserted-by":"crossref","first-page":"e278Se325S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in Orthopedic Surgery Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.mcna.2024.04.005_bib7","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1538-7836.2010.03965.x","article-title":"A\u00a0critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty","volume":"8","author":"DAHL","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000506456","article-title":"Assessing Bleeding Risk in Bariatric Surgeries: A Retrospective Analysis Study","volume":"38","author":"Susmallian","year":"2020","journal-title":"Dig Dis"},{"key":"10.1016\/j.mcna.2024.04.005_bib9","first-page":"e20200109","volume":"20","author":"Chindamo","year":"2021"},{"issue":"23","key":"10.1016\/j.mcna.2024.04.005_bib10","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Advances"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.arth.2007.11.006","article-title":"Portable Compression Device and Low-Molecular-Weight Heparin Compared With Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Joint Arthroplasty","volume":"23","author":"Edwards","year":"2008","journal-title":"J\u00a0Arthroplasty"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11239-009-0351-1","article-title":"Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study","volume":"28","author":"Spyropoulos","year":"2009","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2024.04.005_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamasurg.2018.0015","article-title":"Venous Thromboembolism Prevention in Emergency General Surgery","volume":"153","author":"Murphy","year":"2018","journal-title":"JAMA Surgery"},{"issue":"9610","key":"10.1016\/j.mcna.2024.04.005_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","article-title":"Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study","volume":"8","author":"Kakkar","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"9275","key":"10.1016\/j.mcna.2024.04.005_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)05249-1","article-title":"Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials","volume":"358","author":"Eikelboom","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.mcna.2024.04.005_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-156-10-201205150-00423","article-title":"Prolonged Versus Standard-Duration Venous Thromboprophylaxis in Major Orthopedic Surgery","volume":"156","author":"Sobieraj","year":"2012","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mcna.2024.04.005_bib19","doi-asserted-by":"crossref","first-page":"e2345883","DOI":"10.1001\/jamanetworkopen.2023.45883","article-title":"Venous thromboembolism in total hip and total knee arthroplasty","volume":"6","author":"Simon","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.2022.13416","article-title":"Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: The CRISTAL Randomized Trial","volume":"328","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mcna.2024.04.005_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2205973","article-title":"Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture","volume":"388","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mcna.2024.04.005_bib22","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1111\/jth.15890","article-title":"Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery\u2014Systematic review and meta-analysis","volume":"20","author":"Presume","year":"2022","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib23","first-page":"CD006681","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization","author":"Zee","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"journal-title":"NICE Guideline [NG89]","article-title":"Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism","year":"2019","key":"10.1016\/j.mcna.2024.04.005_bib24"},{"issue":"2","key":"10.1016\/j.mcna.2024.04.005_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SLA.0b013e3181b7fca6","article-title":"A\u00a0validation study of a retrospective venous thromboembolism risk scoring method","volume":"251","author":"Bahl","year":"2010","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib26","first-page":"CD004318","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery","volume":"8","author":"Felder","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.mcna.2024.04.005_bib27","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Guideline Update","volume":"41","author":"Key","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mcna.2024.04.005_bib28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jtcvs.2022.05.041","article-title":"Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery","volume":"165","author":"Shargall","year":"2023","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.mcna.2024.04.005_bib29","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.mayocp.2020.06.015","article-title":"Perioperative venous thromboembolism prophylaxis","volume":"95","author":"Bartlett","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib30","volume":"28","author":"Mechanick","year":"2020","journal-title":"Obesity Medicine Association, and American Society of Anesthesiologists. Obesity"},{"year":"2022","series-title":"EAU Guidelines on Thromboprophylaxis in Urological Surgery","author":"Tikkinen","key":"10.1016\/j.mcna.2024.04.005_bib31"},{"issue":"1","key":"10.1016\/j.mcna.2024.04.005_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000004445","article-title":"Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin, Number 232","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2024.04.005_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/157016111793744805","article-title":"Perioperative Thromboprophylaxis and Anticoagulation in Patients Undergoing Non-Cardiac Vascular Surgery","volume":"9","author":"Khan","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"10.1016\/j.mcna.2024.04.005_bib34","article-title":"Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis","volume":"4","author":"Ho","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.mcna.2024.04.005_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009658.pub2","article-title":"Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery","author":"Di Nisio","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2024.04.005_bib36","first-page":"331","article-title":"Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey","volume":"57","author":"Shargall","year":"2019","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib37","first-page":"627","article-title":"Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology\u2013Head and Neck Surgery: State of the Art Review","volume":"158","author":"Cramer","year":"2018"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib38","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hed.24758","article-title":"Systematic review and meta-analysis of venous thromboembolism in otolaryngology-head and neck surgery","volume":"39","author":"Moubayed","year":"2017","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.mcna.2024.04.005_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/TA.0000000000003475","article-title":"American Association for the Surgery of Trauma\/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma","volume":"92","author":"Yorkgitis","year":"2022","journal-title":"J\u00a0Trauma Acute Care Surg"},{"issue":"5","key":"10.1016\/j.mcna.2024.04.005_bib40","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib41","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s11606-020-05904-0","article-title":"Oral Anticoagulant Utilization in the United States and United Kingdom","volume":"35","author":"Colacci","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"issue":"21","key":"10.1016\/j.mcna.2024.04.005_bib42","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2024.04.005_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bjs.10643","article-title":"Population-based incidence rate of inpatient and outpatient surgical procedures in a high-income country","volume":"105","author":"Omling","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.mcna.2024.04.005_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2017.08.011","article-title":"International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries","volume":"194","author":"Steinberg","year":"2017","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.mcna.2024.04.005_bib45","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.mcna.2024.04.005_bib46","doi-asserted-by":"crossref","unstructured":"Narouze S, Benzon HT, Provenzano D, et\u00a0al. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition): Guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018 Apr;43(3):225-262.","DOI":"10.1097\/AAP.0000000000000700"},{"issue":"22","key":"10.1016\/j.mcna.2024.04.005_bib47","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2024.04.005_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2009.03685.x","article-title":"Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?","volume":"8","author":"Steib","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.mcna.2024.04.005_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","article-title":"Temporary discontinuation of warfarin therapy: changes in the international normalized ratio","volume":"122","author":"White","year":"1995","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib50","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12613","article-title":"Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial","volume":"12","author":"Schulman","year":"2014","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.amjmed.2019.01.004","article-title":"Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review","volume":"132","author":"Baumgartner","year":"2019","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.mcna.2024.04.005_bib52","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/jth.14903","article-title":"Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry-based cohort study","volume":"18","author":"Barnes","year":"2020","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"9","key":"10.1016\/j.mcna.2024.04.005_bib53","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2024.04.005_bib54","doi-asserted-by":"crossref","first-page":"n1205","DOI":"10.1136\/bmj.n1205","article-title":"PERIOP2 Investigators. operative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial","volume":"373","author":"Kovacs","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.mcna.2024.04.005_bib55","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-135-6-200109180-00008","article-title":"Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin","volume":"135","author":"Hylek","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib57","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/rth2.12320","volume":"4","author":"Levy","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"10.1016\/j.mcna.2024.04.005_bib58","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17425255.2023.2287472","article-title":"Pharmacokinetics and pharmacodynamics of direct oral anticoagulants","volume":"19","author":"Hindley","year":"2023","journal-title":"Expet Opin Drug Metabol Toxicol"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"14","key":"10.1016\/j.mcna.2024.04.005_bib60","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mcna.2024.04.005_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10840-019-00646-4","article-title":"Peri-procedural use of direct anticoagulation agents during cardiac device implantation: vitamin K antagonists vs direct oral anticoagulants","volume":"58","author":"Pillarisetti","year":"2020","journal-title":"J\u00a0Intervent Card Electrophysiol"},{"issue":"5","key":"10.1016\/j.mcna.2024.04.005_bib62","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","article-title":"A\u00a0prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial","volume":"4","author":"Reynolds","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.mcna.2024.04.005_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euy148","article-title":"Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events","volume":"21","author":"Nakamura","year":"2019","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.mcna.2024.04.005_bib64","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/eurheartj\/ehy870","article-title":"When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study","volume":"40","author":"Yu","year":"2019","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.mcna.2024.04.005_bib65","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2024.04.005_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/trf.15560","article-title":"Impact of rivaroxaban plasma concentration on perioperative red blood cell loss","volume":"60","author":"Kaserer","year":"2020","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.mcna.2024.04.005_bib67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00068-022-02041-7","article-title":"Role of DOAC plasma concentration on perioperative blood loss and transfusion requirements in patients with hip fractures","volume":"49","author":"Hofer","year":"2023","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"5","key":"10.1016\/j.mcna.2024.04.005_bib68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.mcna.2024.04.005_bib69","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet\u00a0alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2024.04.005_bib70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum","volume":"94","author":"Cuker","year":"2019","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.mcna.2024.04.005_bib71","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/jgs.14288","article-title":"Potential effect of substituting estimated glomerular filtration rate for estimated creatinine clearance for dosing of direct oral anticoagulants","volume":"64","author":"Schwartz","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.mcna.2024.04.005_bib72","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.mcna.2020.02.005","article-title":"Periprocedural management of oral anticoagulation","volume":"104","author":"Shaw","year":"2020","journal-title":"Med Clin North Am"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252400052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252400052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T21:18:44Z","timestamp":1727385524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571252400052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S002571252400052X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2024.04.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Clinics of North America\u2014Periprocedural Antithrombotics","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}